Statement
14 Oct 2024
WHO EMRO RC71: Regional flagship initiative 1: Expanding equitable access to medical products
On 14 October 2024 in Doha, Qatar, IFPMA delivered a statement at the 71st session of the WHO EMRO Regional Committee on the Regional flagship initiative 1: Expanding equitable access to medical products.
Read more
Statement
9 Oct 2024
77th WHO SEARO Regional Committee: Agenda items 8.2 and 9.6 on NCDs and UHC
On 9 October 2024 in New Delhi, India, IFPMA delivered a statement at the 77th WHO SEARO Regional Committee on Agenda items 8.2 and 9.6: NCDs and UHC.
Read more
Statement
3 Oct 2024
61st PAHO Directing Council: Access and rational use of strategic and high-cost medicines and other health technologies
On 3 October 2024 in Washington, D.C., IFPMA and FIFARMA delivered a statement at the 61st PAHO Directing Council on a report focused on access and rational use of strategic and high-cost medicines and other health technologies.
Read more